PDPN and neoplasm: At least, MS-1 mAb exhibits anti-tumor activity against podoplanin-positive PC-10 xenograft tumor in immune-deficient NOD-SCID mouse [91], and the recombinant single-chain antibody variable region fragment of MS-1 also suppresses podoplanin-mediated metasiasis [89].